W
WLC

Latest

Longevity Medicine News

Research, clinical trials, regulatory updates, and industry analysis from the longevity medicine world.

All clinics diagnostics longevity clinics longevity-clinic-comparison regulation best-longevity-clinics evidence-based healthspan industry-news longevity longevity-treatments aging research biohacking clinical-trials clinique-la-prairie longevity-clinics longevity-diagnostics longevity-industry longevity-science NAD-therapy peptide-therapy progevita aging aging-research biomarkers BPC-157 business cleveland-clinic clinic-comparison clinical trials evidence FDA-regulation fountain-life hospital-longevity-programs innovation lanserhof longevity treatments longevity-medicine longevity-medicine-europe NMN NR plasmapheresis preventive-health research sha-wellness-clinic stem cells affordable-longevity-europe aging frailty AI diagnostics AI-drug-discovery allogeneic stem cells Alzheimer-disease AMAALA anti-aging-science anti-aging-treatments ARPA-H Austin-Texas best-longevity-clinics-europe best-longevity-clinics-spain best-longevity-clinics-usa biograph biological age reversal biological-age blood-filtering-therapy buchinger-wilhelmi cellular-senescence centenarians chenot-palace Cleveland Clinic compounding-pharmacies cruise-ship-wellness drug-combo editorial EMA epigenetic-clock epigenetics european-longevity-clinics european-wellness evidence-based-medicine executive health executive-health franchises genomics geroscience Human Longevity human-longevity-inc industry-trends inflammation investment ipamorelin joe-rogan longevity medicine longevity-clinic-europe longevity-clinic-guide longevity-clinics-expansion longevity-expansion longevity-medical-tourism longevity-ranking longevity-testing longevity-tourism luxury-longevity luxury-wellness-europe marketing mayo-clinic media medical tourism men health MSC therapy mTOR inhibitors NAD+ neurodegenerative-disease Niagen oxytocin palazzo-fiuggi peptides performance pharmaceutical-industry prevention privacy programs proteomics protocols rapamycin regenerative regenerative medicine regenerative-medicine regulatory-policy risk Saudi-Arabia senolytics sports medicine startups stem cell therapy TGF-beta therapeutic plasma exchange therapeutic-fasting TPE treatment-comparison treatments United States US-longevity-clinics UT Health San Antonio VO2-max Ways2Well wellness
Sex-specific longitudinal reversal of aging in old frail mice — Aging-US, 2025 Peer-reviewed

Oxytocin + Alk5 Inhibitor Combo Boosts Lifespan 70% in Elderly Mice: What the Science Actually Shows

A UC Berkeley study found that combining oxytocin with an Alk5 inhibitor extended lifespan by 70% in frail elderly male mice. Benefits were sex-specific — females showed no lasting improvement. Here's what the data says and whether it could reach humans.

oxytocin TGF-beta aging-research